ImmunityBio (IBRX) Net Income (2014 - 2026)
ImmunityBio's Net Income was -$230.39 million in Q2 2026, compared with -$92.57 million a year earlier.
Powered by 
Analysis
ImmunityBio (IBRX) Net Income (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, ImmunityBio's Net Income was -$992.42 million through Jun 30, 2026; for FY2025, it was -$351.47 million.
- In earlier years, Net Income was -$413.65 million in FY2024, -$583.85 million in FY2023, -$417.32 million in FY2022 and -$349.85 million in FY2021.
- Quarterly Net Income has moved between -$632.8 million (Q1 2026) and -$59.18 million (Q4 2024) over five years.
- Per Business Quant data, IBRX's Net Income in the three quarters before Q2 2026 was -$632.8 million (Q1 2026), -$61.96 million (Q4 2025) and -$67.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -237.00 Mn |
| 10 | ImmunityBio | 9.77 Bn | 8.54 Bn | 50.94 Mn | -230.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -230.39 Mn |
| Mar 31, 2026 | -632.80 Mn |
| Dec 31, 2025 | -61.96 Mn |
| Sep 30, 2025 | -67.27 Mn |
| Jun 30, 2025 | -92.57 Mn |
| Mar 31, 2025 | -129.67 Mn |
| Dec 31, 2024 | -59.18 Mn |
| Sep 30, 2024 | -85.75 Mn |
| Jun 30, 2024 | -134.58 Mn |
| Mar 31, 2024 | -134.13 Mn |
| Dec 31, 2023 | -233.41 Mn |
| Sep 30, 2023 | -95.64 Mn |
| Jun 30, 2023 | -138.21 Mn |
| Mar 31, 2023 | -116.58 Mn |
| Dec 31, 2022 | -108.33 Mn |
| Sep 30, 2022 | -111.16 Mn |
| Jun 30, 2022 | -94.84 Mn |
| Mar 31, 2022 | -103.00 Mn |
| Dec 31, 2021 | -91.55 Mn |
| Sep 30, 2021 | -88.43 Mn |
API Access
ImmunityBio Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();